Page last updated: 2024-10-30

edaravone and Glycogen Storage Disease Type II

edaravone has been researched along with Glycogen Storage Disease Type II in 2 studies

Glycogen Storage Disease Type II: An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sowell, J1
Wood, T1
Rozaklis, T1
Ramsay, SL1
Whitfield, PD1
Ranieri, E1
Hopwood, JJ1
Meikle, PJ1

Other Studies

2 other studies available for edaravone and Glycogen Storage Disease Type II

ArticleYear
Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses.
    Analytica chimica acta, 2011, Feb-07, Volume: 686, Issue:1-2

    Topics: Antipyrine; Chromatography, High Pressure Liquid; Edaravone; Fucosidosis; Glycogen Storage Disease T

2011
Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry.
    Clinical chemistry, 2002, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Antipyrine; Child; Child, Preschool; Edaravone; Glycogen Storage Disease Type II;

2002